AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Orbis inc canada11/14/2023 Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2023 Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023 Reports Earnings Results for the First Quarter Ended March 31, 2023 Revises Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023 ![]() ![]() Announces Second Quarter-End Dividend for the Six Months Ended June 30, 2023, Payable on SeptemProvides Year-End Dividend Guidance for the Fiscal Year Ending December 31, 2023 announced that it has received ¥170 million in funding from Toppan Inc., Pola Orbis Holdings Inc., SMBC Venture Capital Co., Ltd., THE SEED Announces Establishment of New SubsidiaryĬhai Inc. Pola Orbis Holdings' Creates New Subsidiary Pola Medical to Expand its Presence in Aesthetic Medicine Field Note: The impact on the consolidated financial results is estimated based on the information available today and the actual impact may differ due to various changes of situation in the future. The Company will promptly disclose information if any revisions to business forecasts become necessary, or if any other matters which require disclosure arise. The impact on consolidated business results for fiscal 2023 will be minimal. Medicine-related fields, manufacturing and sale of deliverables, sale Research and development in the dermatology and aesthetic Noriko Suenobu, Representative Director and President Overview of the subsidiary that will engage in this new businessĥ60 Kashio-cho,Totsuka-ku,Yokohama-shi, Kanagawa
0 Comments
Read More
Leave a Reply. |